CDH5 and Alzheimer disease: Results from another human post‐mortem study indicated the downregulation of AJ protein vascular endothelial (VE)‐cadherin in the brain vessels in both MCI and AD patients, along with increased levels of soluble VE‐cadherin in the blood plasma [44].